APLIF
Price:
$0.015
Market Cap:
$3.03M
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for F...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
APLIF
According to Appili Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.26M. This represents a change of -0.10% compared to the average of 14.27M of the last 4 quarters.
The mean historical Enterprise Value of Appili Therapeutics Inc. over the last ten years is 19.85M. The current 14.26M Enterprise Value has changed 7.08% with respect to the historical average. Over the past ten years (40 quarters), APLIF's Enterprise Value was at its highest in in the September 2020 quarter at 71.33M. The Enterprise Value was at its lowest in in the December 2017 quarter at 0.
Average
19.85M
Median
15.31M
Minimum
6.32M
Maximum
55.66M
Discovering the peaks and valleys of Appili Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 302.24%
Maximum Annual Enterprise Value = 55.66M
Minimum Annual Increase = -88.64%
Minimum Annual Enterprise Value = 6.32M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 15.31M | 24.13% |
| 2024 | 12.33M | 26.53% |
| 2023 | 9.75M | 54.21% |
| 2022 | 6.32M | -88.64% |
| 2021 | 55.66M | 302.24% |
| 2020 | 13.84M | -30.55% |
| 2019 | 19.92M | -10.34% |
| 2018 | 22.22M | -4.69% |
The current Enterprise Value of Appili Therapeutics Inc. (APLIF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.46M
5-year avg
19.87M
10-year avg
19.85M
Appili Therapeutics Inc.’s Enterprise Value is greater than Algernon Pharmaceuticals Inc. (2.65M), greater than ReNeuron Group plc (-5684904.70), greater than Ayala Pharmaceuticals, Inc. (7.85M), greater than Universal Ibogaine Inc. (3.95M), greater than Restart Life Sciences Corp. (3.44M), greater than Regen BioPharma, Inc. (1.32M), greater than VG Life Sciences Inc. (2.11M), greater than America Great Health (4.75M), greater than Imagion Biosystems Limited (6.83M), greater than Health Sciences Group, Inc. (505.72K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.65M | $1.92M | |
| -5684904.70 | $62.89K | |
| 7.85M | $4.41M | |
| 3.95M | $1.95M | |
| 3.44M | $2.27M | |
| 1.32M | $283.99K | |
| 2.11M | $2.11M | |
| 4.75M | $2.12M | |
| 6.83M | $2.21M | |
| 505.72K | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Appili Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Appili Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Appili Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Appili Therapeutics Inc. (APLIF)?
What is the 3-year average Enterprise Value for Appili Therapeutics Inc. (APLIF)?
What is the 5-year average Enterprise Value for Appili Therapeutics Inc. (APLIF)?
How does the current Enterprise Value for Appili Therapeutics Inc. (APLIF) compare to its historical average?